Progression of JAK2-mutant polycythemia vera to CALR-mutant myelofibrosis severely impacts on disease phenotype and response to therapy

Morten Orebo Holmström*, Guy W. Novotny, Jesper Petersen, Mia Aaboe-Jørgensen, Hans Carl Hasselbalch, Mads H. Andersen, Signe Ledou Nielsen, Daniel El Fassi, Claudia Schöllkopf

*Corresponding author for this work
2 Citations (Scopus)
Original languageEnglish
JournalLeukemia and Lymphoma
ISSN1042-8194
DOIs
Publication statusPublished - 10 Nov 2019

Cite this